Overview
Kenneth Rosenbaum, MD, started with Children’s National Hospital in 1972 after completing his medical genetics training at Johns Hopkins University in 1971. Dr. Rosenbaum has consistently been voted the top physician at Children’s National over the past 10 years. Dr. Rosenbaum has overseen dysmorphic research projects at the National Institutes of Health, in Egypt, and here at Children’s National. Dr. Rosenbaum is the co-director of the Down Syndrome Clinic and the NF clinic.
Dr. Rosenbaum is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Triple X Syndrome, and Williams Syndrome.
Dr. Rosenbaum is board certified in Clinical Cytogenetics: American Board Of Medical Genetics And Genomics, 1982, Clinical Genetics (MD): American Board Of Medical Genetics And Genomics, 1982, and Pediatrics: American Board Of Pediatrics, 1976. He is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 1 clinical trial.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
9850 Key West Avenue, Rockville, MD 20850
7125 13th Place Northwest, Washington, DC 20012
111 Michigan Avenue Northwest, Childrens National Telemedicine, Washington, DC 20010
111 Michigan Avenue Northwest, Washington, DC 20010
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Children's National Hospital
Roger Packer is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Packer is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Gliomatosis Cerebri.
Ozlem Goker-Alpan MD LLC
Ozlem Goker is a primary care provider, practicing in Pediatrics in Fairfax, Virginia. Dr. Goker is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Gaucher Disease, Fabry Disease, Gaucher Disease Type 1, and Pompe Disease.
Children's National Hospital
Andrea Gropman is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Gropman is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Klinefelter Syndrome, Urea Cycle Disorders (UCD), MELAS Syndrome, Ornithine Transcarbamylase Deficiency, and Hormone Replacement Therapy (HRT).
Frequently Asked Questions about Dr. Kenneth N. Rosenbaum
How do I make an appointment with Dr. Kenneth N. Rosenbaum?
You can book an appointment with Dr. Kenneth N. Rosenbaum by calling their office at 301-765-5400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kenneth N. Rosenbaum a top-rated expert for Neurofibromatosis Type 1 (NF1)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kenneth N. Rosenbaum is classified as an Advanced expert for Neurofibromatosis Type 1 (NF1), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kenneth N. Rosenbaum specialize in?
While Dr. Kenneth N. Rosenbaum is a Pediatrics, they have specific expertise in Neurofibromatosis Type 1 (NF1), Neurofibromatosis, and Triple X Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.
Does Dr. Kenneth N. Rosenbaum participate in research or clinical trials?
Yes. Dr. Kenneth N. Rosenbaum has published 15 articles and abstracts on conditions like Neurofibromatosis Type 1 (NF1). You can view a list of Dr. Kenneth N. Rosenbaum's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kenneth N. Rosenbaum accept my insurance?
Dr. Kenneth N. Rosenbaum accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 301-765-5400 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- NeurofibromatosisDr. Rosenbaum isAdvanced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Dr. Rosenbaum isAdvanced. Learn about Neurofibromatosis Type 1 (NF1).
- Triple X SyndromeDr. Rosenbaum isAdvanced. Learn about Triple X Syndrome.
- Experienced
- 15q11.2 MicrodeletionDr. Rosenbaum isExperienced. Learn about 15q11.2 Microdeletion.
- 2q37 Deletion SyndromeDr. Rosenbaum isExperienced. Learn about 2q37 Deletion Syndrome.
- 3MC SyndromeDr. Rosenbaum isExperienced. Learn about 3MC Syndrome.
- 3p Deletion SyndromeDr. Rosenbaum isExperienced. Learn about 3p Deletion Syndrome.
- 47 XYY SyndromeDr. Rosenbaum isExperienced. Learn about 47 XYY Syndrome.
- Aarskog SyndromeDr. Rosenbaum isExperienced. Learn about Aarskog Syndrome.